Violation Tracker Individual Record
Company:
Schering-Plough Corporation
Current Parent Company:
Merck
Penalty:
$91,602,000
Year:
2006
Date:
August 29, 2006
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Secondary Offense:
False Claims Act and related
Violation Description:
Schering-Plough agreed to pay $91.6 million to settle multistate litigation alleging it engaged in illegal sales and marketing programs of its drugs Temodar and Intron A and that it engaged in Medicaid fraud irelating to its Claritin RediTabs and K-Dur products. This was part of a larger $435 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-schering-p...
Level of Government:
state
Action Type:
agency action
Agency:
Multistate Attorneys General Case
Civil or Criminal Case:
civil
HQ Country of Parent:
USA
HQ State of Parent:
New Jersey
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
